Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis

Publisher： John Wiley & Sons Inc

E-ISSN： 2328-9503|2|5|445-455

ISSN： 2328-9503

Source： Annals Of Clinical And Translational Neurology, Vol.2, Iss.5, 2015-05, pp. : 445-455

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autologous T-Cell Vaccination for Multiple Sclerosis: A Perspective on Progress

By Vandenbark Arthur A.   Abulafia-Lapid Rivka  

BioDrugs, Vol. 22, Iss. 4, 2008-01 ,pp. : 265-273

Adis International

Access to resources Recommend Favorite

Multiple sclerosis: pregnancy and motherhood

By Anderson Joanna   Wallace Louise  

The Practising Midwife, Vol. 16, Iss. 6, 2013-06 ,pp. : 28-31

Medical Education Solutions Limited

Access to resources Recommend Favorite

Expanded CD8 T‐cell sharing between periphery and CNS in multiple sclerosis

By  

Annals Of Clinical And Translational Neurology, Vol. 2, Iss. 6, 2015-06 ,pp. : 609-622

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Intravenous Immunoglobulin in Multiple Sclerosis

By Achiron A.  

BioDrugs, Vol. 9, Iss. 6, 1998-06 ,pp. : 465-475

Adis International

Access to resources Recommend Favorite

Aging, Widowhood, Multiple Sclerosis, and a Dog

By Brickner Marian  

Care Management Journals, Vol. 13, Iss. 1, 2012-03 ,pp. : 33-36

Springer Publishing Company

Access to resources Recommend Favorite